Epigenomics AG (LON:0QXH)

London flag London · Delayed Price · Currency is GBP · Price in EUR
1.060
+0.178 (20.18%)
At close: Feb 25, 2026
Market Cap737.42K -10.5%
Revenue (ttm)3.43K -97.1%
Net Income-2.37M
EPS-2.70
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume50
Average Volume2,705
Open1.060
Previous Close0.882
Day's Range1.060 - 1.060
52-Week Range0.882 - 1.500
Betan/a
RSI21.58
Earnings DateApr 1, 2026

About Epigenomics AG

Epigenomics AG does not have significant operations. Previously, the company was involved in liquid biopsy for the early detection of cancer. The company was founded in 1998 and is headquartered in Heidelberg, Germany. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1998
Employees 3
Stock Exchange London Stock Exchange
Ticker Symbol 0QXH

Financial Performance

Financial numbers in EUR Financial Statements